Literature DB >> 33796891

The role of protein hydrolysates in prolonging viability and enhancing antibody production of CHO cells.

Ismael Obaidi1,2, Letícia Martins Mota1,3, Andrew Quigley1, Michael Butler4,5.   

Abstract

Four independent mAb-producing CHO cell lines were grown in media supplemented with one of seven protein hydrolysates of animal and plant origin. This generated a 7x4 matrix of replicate cultures which was analysed for viable cell density and mAb productivity. In all cultures, a consistent growth rate was shown in batch culture up to 4 to 5 days. Differences between cultures appeared in the decline phase which was followed up to 7 days beyond the start of the cultures. There was a marginal but significant overall increase (x1.1) in the integral viable cell density (IVCD) in the presence of hydrolysate but a more substantial increase in the cell-specific mAb (qMab) productivity (x1.5). There were individual differences between hydrolysates in terms of enhancement of mAb productivity, the highest being a 166% increase of mAb titre (to 117 mg/L) in batch cultures of CHO-EG2 supplemented with UPcotton hydrolysate. The effect of one of the most active hydrolysates (HP7504) on antibody glycosylation was investigated. This showed no change in the predominant seven glycans produced but a significant increase in the galactosylation and sialylation of some but not all the antibodies. Overall, the animal hydrolysate, Primatone and two cotton-derived hydrolysates provided the most substantial benefit for enhanced productivity. The cotton-based hydrolysates can be viewed as valuable supplements for animal-derived component-free (ADCF) media and as a source for the investigation of chemically defined bioactive components. KEY POINTS: • Protein hydrolysates enhanced both IVCD & qMab; the effect on qMab being consistently greater. • Cotton-based hydrolysates showed high bioactivity and potential for use in serum-free media. • Enhanced galactosylation and sialylation was shown for some of the Mabs tested.

Entities:  

Keywords:  CHO cells; Glycosylation; Monoclonal antibodies; Protein hydrolysates; Serum-free media

Mesh:

Substances:

Year:  2021        PMID: 33796891     DOI: 10.1007/s00253-021-11244-8

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  54 in total

Review 1.  Bioactive peptides of animal origin: a review.

Authors:  Z F Bhat; Sunil Kumar; Hina Fayaz Bhat
Journal:  J Food Sci Technol       Date:  2015-01-21       Impact factor: 2.701

Review 2.  Fetal bovine serum-free culture of endothelial progenitor cells-progress and challenges.

Authors:  E Bauman; P L Granja; C C Barrias
Journal:  J Tissue Eng Regen Med       Date:  2018-05-30       Impact factor: 3.963

3.  Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications.

Authors:  Christelle Doucet; Isabelle Ernou; Yizhou Zhang; Jean-Roch Llense; Laurent Begot; Xavier Holy; Jean-Jacques Lataillade
Journal:  J Cell Physiol       Date:  2005-11       Impact factor: 6.384

4.  Differential tumor-targeting abilities of three single-domain antibody formats.

Authors:  Andrea Bell; Zheng J Wang; Mehdi Arbabi-Ghahroudi; Tingtung A Chang; Yves Durocher; Ulrike Trojahn; Jason Baardsnes; Maria L Jaramillo; Shenghua Li; Toya N Baral; Maureen O'Connor-McCourt; Roger Mackenzie; Jianbing Zhang
Journal:  Cancer Lett       Date:  2009-08-28       Impact factor: 8.679

5.  Metabolic flux analysis of hybridoma cells in different culture media using mass balances.

Authors:  H P Bonarius; V Hatzimanikatis; K P Meesters; C D de Gooijer; G Schmid; J Tramper
Journal:  Biotechnol Bioeng       Date:  1996-05-05       Impact factor: 4.530

6.  A study of monoclonal antibody-producing CHO cell lines: what makes a stable high producer?

Authors:  Janet Chusainow; Yuan Sheng Yang; Jessna H M Yeo; Poh Choo Toh; Parisa Asvadi; Niki S C Wong; Miranda G S Yap
Journal:  Biotechnol Bioeng       Date:  2009-03-01       Impact factor: 4.530

7.  Establishment of a mammalian cell line suitable for industrial production of recombinant protein using mutations induced by high-energy beam radiation.

Authors:  Yasuhito Chida; Keiichi Takagi; Satoshi Terada
Journal:  Cytotechnology       Date:  2013-05-10       Impact factor: 2.058

8.  Plant protein hydrolysates support CHO-320 cells proliferation and recombinant IFN-gamma production in suspension and inside microcarriers in protein-free media.

Authors:  J S Ballez; J Mols; C Burteau; S N Agathos; Y J Schneider
Journal:  Cytotechnology       Date:  2004-03       Impact factor: 2.058

9.  Peptone Supplementation of Culture Medium Has Variable Effects on the Productivity of CHO Cells.

Authors:  Fatemeh Davami; Lucia Baldi; Yashas Rajendra; Florian M Wurm
Journal:  Int J Mol Cell Med       Date:  2014

Review 10.  Recent advances in technology supporting biopharmaceutical production from mammalian cells.

Authors:  M Butler; A Meneses-Acosta
Journal:  Appl Microbiol Biotechnol       Date:  2012-10-05       Impact factor: 4.813

View more
  3 in total

Review 1.  Effects and mechanisms of animal-free hydrolysates on recombination protein yields in CHO cells.

Authors:  Qiujie Du; Xi Zhang; Tianyun Wang; Xiaoyin Wang
Journal:  Appl Microbiol Biotechnol       Date:  2022-10-14       Impact factor: 5.560

Review 2.  Expression of mammalian proteins for diagnostics and therapeutics: a review.

Authors:  Jacqueline Kar Kei Mark; Crystale Siew Ying Lim; Fazlina Nordin; Gee Jun Tye
Journal:  Mol Biol Rep       Date:  2022-06-08       Impact factor: 2.742

3.  On-line untargeted metabolomics monitoring of an Escherichia coli succinate fermentation process.

Authors:  Joan Cortada-Garcia; Jennifer Haggarty; Tessa Moses; Rónán Daly; Susan Alison Arnold; Karl Burgess
Journal:  Biotechnol Bioeng       Date:  2022-07-15       Impact factor: 4.395

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.